Similarly, these results indicated that the PNN gene could be a useful prognosis feature for PCa patients in clinical practice related to tumour progression and poor prognosis (Wei et al., 2016; Yang et al., 2016; Tang et al., 2020; Jin et al., 2021). The gene discussed is PNN; the disease is posterior cortical atrophy.